Leishmaniasis
📧 Sign up to get email alerts when something new happens for Leishmaniasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Diagnosis and Treatment of Leishmania Infections
This clinical trial update shows that a study on the diagnosis and treatment of Leishmania infections is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology
This clinical trial update notes the introduction of PCR methods in microbiology and parasitology, with the study currently recruiting for m…
-
CLINICAL_TRIALS withdrawal · 2025-04-27Clinical Trial Update: Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
A pregnancy registry trial evaluating miltefosine (Impavido) for leishmaniasis has been withdrawn.
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases [NA]
A Montpellier-based clinical trial is assessing serological exposure of professionals to multiple zoonotic pathogens, with status NOT_YET_RE…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil [Phase 2]
Phase 2 clinical trial evaluating miltefosine in combination with pentoxifylline for mucosal and cutaneous leishmaniasis in Brazil.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly [Phase 2, Phase 3]
Pilot study evaluating an oral treatment for American tegumentary leishmaniasis (cutaneous and mucosal forms) in elderly participants; curre…
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects [Phase 1]
Phase 1 trial update on safety, tolerability, and pharmacokinetics of GSK3186899 in healthy subjects; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis [Phase 2]
Phase 2 trial evaluating topical liposomal amphotericin B gel for cutaneous leishmaniasis has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Intralesional Antimony for Bolivian Cutaneous Leishmaniasis [Phase 2]
A Phase 2 clinical trial evaluating intralesional antimony for Bolivian cutaneous leishmaniasis has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients [Phase 2]
Phase 2 trial evaluating 18-Methoxycoronaridine for efficacy, safety, and tolerability in cutaneous leishmaniasis is underway but status is …
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Use of Sodium Stibogluconate as a Treatment for Leishmaniasis [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating sodium stibogluconate as a treatment for leishmaniasis, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis [Phase 2]
Phase 2 clinical trial update for a fourth-generation Immucillin derivative (DI4G) associated therapy in cutaneous leishmaniasis has complet…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Sodium Stibogluconate Treatment of Leishmaniasis [Phase 2]
A Phase 2 clinical trial evaluating sodium stibogluconate for leishmaniasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine [Phase 1]
This update notes the completion of a Phase 1 trial evaluating LEISH-F3 vaccines with GLA-SE or MPL-SE adjuvants for leishmaniasis.
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis [Phase 2]
A Phase 2 clinical trial evaluating miltefosine for mucocutaneous leishmaniasis has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers [Phase 1]
Phase 1 assessment of the LEISH-F3 vaccine in healthy adult volunteers has been completed, reporting safety and immunogenicity data for leis…
-
CLINICAL_TRIALS research · 2013-07-11Clinical Trial Update: The Healthcare Professionals and the Leishmaniasis
A completed clinical trial evaluating knowledge among healthcare professionals about Leishmaniasis.
-
CLINICAL_TRIALS trial_result · 2009-11-18Clinical Trial Update: Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0) [Phase 2, Phase 3]
Phase 2/3 trial update of a killed Leishmania vaccine tested in healthy volunteers, reporting safety and efficacy assessments with the study…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Clinical Investigation of Infections Due to Leishmanial Parasites
This entry notes the completion of a clinical trial investigating infections caused by leishmanial parasites. It was sponsored by the Nation…
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: Miltefosine for Mucosal Leishmaniasis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating miltefosine for mucosal leishmaniasis has completed.